Moderna outlines oncology expansion and mid-term growth strategy at Analyst Day
Moderna highlighted oncology development and mid-term growth at its 2026 Analyst Day, advanced intismeran toward potential commercialization and reaffirmed guidance.
Moderna highlighted oncology development and mid-term growth at its 2026 Analyst Day, advanced intismeran toward potential commercialization and reaffirmed guidance.